How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
Conversely, MM loss contributes to homeostatic adaptations that reduce energy expenditure during weight loss, potentially accelerating weight regain
Abud Bakri There's a big controversy about HCG and compounders and who can compound it and who can't
Shapiro DS, Renock S, Arrington E, Chiodo LA, Liu L
cAMP Signaling and Steroidogenesis Furthermore, it has been thoroughly investigated in advanced laboratory settings for its direct involvement in cellular receptor activation, cyclic AMP (cAMP) signaling pathways, and hormone-mediated gene expression